Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosis
Takashi Sasaki(Keio University), Jun Kudoh(Keio University), Keiji Tanese(Toho University), Kenji Kabashima(Agency for Science, Technology and Research), Shun-ichi Miyakawa(Kawasaki Municipal Hospital), Atsushi Shimizu(Keio University), Masamitsu Kuwahara(Nara Medical University Hospital), Hideyuki Okano(Keio University), Atsuhito Seki(National Center For Child Health and Development), Jun‐ichi Sakabe(Hamamatsu University), Makoto Suematsu(Keio University), Akira Ishiko(Keio University), Asami Hirakiyama(National Center For Child Health and Development), Torayuki Okuyama, Masayuki Amagai(RIKEN Center for Integrative Medical Sciences), Aiko Shiohama(Keio University), Hironori Niizeki(National Center For Child Health and Development), Atsushi Otsuka(Kyoto University)
Cited by 83
Related Papers
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
|Frontiers in Oncology|2018|1.3k
Inflammation-free, gas-permeable, lightweight, stretchable on-skin electronics with nanomeshes
|Nature Nanotechnology|2017|1.1k
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
|Molecular Brain|2012|389
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377